Cantor Morning News | Healthcare

CELG Celgene reports Q2 EPS $0.69 ex-items vs Reuters $0.66. Company reports revenues of $852.7M vs Reuters $821.6M. Guides full year EPS to $2.65-2.70 vs prior $2.60-2.65 and vs Reuters $2.67; guides revenues to $3.40-3.45B vs prior $3.3-3.4B and vs Reuters $3.36B.

MGLN Magellan Health 1.05 v .74c. Revs $741.7M vs $748.3M. Guides FY eps higher

IART Integra reports Q2 EPS $0.68 vs Reuters $0.64 Company reports revenues of $178.6M vs Reuters $176.6M. Reaffirms guidance.

COV Covidien reports Q3 EPS $0.85 ex-items vs Reuters $0.80. Company reports revenues of $2.56B vs Reuters $2.61B.

HRC Hill-Rom Holdings .45c vs .31c. Revs $361M vs $358M. Guides FY eps higher.

PSSI PSS World Medical reports Q1 EPS $0.24 vs Reuters $0.27. Company reports revenues of $478.9M vs Reuters $500.2M.Guides full year EPS to $1.27-1.31 vs Reuters $1.34.

DIN Dine Equity .90c vs .96c. Revs $339M vs $339M

CYH Community Health reports Q2 EPS $0.74 vs Reuters $0.73. Company reports revenues of $3.17B vs Reuters $3.23B.

MYL Mylan reports Q2 EPS $0.37 ex-items vs Reuters $0.38. Company reports revenues of $1.37B vs Reuters $1.34B. Guides full year EPS to $1.55-1.65 vs prior $1.50-1.70 and vs Reuters $1.60; guides revenues to $5.4-5.6B vs prior $5.45-5.75B and vs Reuters $5.49B.

CNMD CONMED reports Q2 EPS $0.32 ex-items vs Reuters $0.26. Company reports revenues of $181.1M vs Reuters $177.1M.Guides Q3 EPS to $0.25 - $0.30 vs Reuters $0.28; guides revenues to approx. $174 - $179M vs Reuters $174.6M. Reaffirms full year EPS guidance of $1.20 - $1.30 vs Reuters $1.20; reaffirms revenue guidance of $ $715 - $725M vs Reuters $719.8M.

IPG Interpublic reports Q2 EPS $0.15 vs Reuters $0.10 Company reports revenues of $1.62B vs Reuters $1.51B.

Sector News, M&A, Capital Raises

AZN FDA panel votes 7-1 to recommend approval of AstraZeneca's Brilinta for certain heart patients

ABII Abraxis announce approval to market ABRAXANE for breast cancer in New Zealand

WSJ article says insured people are not going to the doctor. People are having to pay a larger amount of costs themselves and that possibly lower rates are in the future.

Research Away

AMAG AMAG Pharmaceuticals downgraded to neutral from outperform at RW Baird

ALTH Allos Therapeutics downgraded to sector perform from outperform at RBC Capital

CVS CVS Caremark downgraded to neutral from buy at Bank of America Merrill Lynch

Disclaimer: Prepared by staff of Cantor Fitzgerald & Co. ("Cantor") and is for information purposes only. It is not intended to form the basis of any investment decision, should not be considered a recommendation by Cantor or any other person and does not constitute an offer or solicitation with respect to the purchase or sale of any investment nor is it a confirmation of terms. Any calculations and valuations presented herein are intended as a basis for discussion. Sources of information are believed to be reliable but Cantor makes no representation and gives no warranty that the information contained herein is accurate or complete. Any opinions or estimates given may change. Cantor undertakes no obligation to provide recipients with any additional information or any update to or correction of the information contained herein. This material is intended solely for institutional investors and investors who Cantor reasonably believes are institutional investors. Cantor, its officers, employees, affiliates and partners shall not be liable to any person in any way whatsoever for any losses, costs or claims howsoever arising from any inaccuracies or omissions in the information contained herein or any reliance on that information. Cantor may have positions in financial instruments mentioned, may have acquired such positions at prices no longer available, and may have interests different or adverse to your interests. No liability is accepted by Cantor for any loss that may arise from any use of the information contained herein or derived here from. This product may not be reproduced or redistributed outside the recipient's organization. Sources: Cantor Fitzgerald & Co., Reuters, Bloomberg, CNBC, Dow Jones, Marketwatch, Trade-Alert, and the Wall Street Journal. ***All eco data from Bloomberg and DJ